Skip to main content
KORU Medical Systems, Inc. logo

KORU Medical Systems, Inc. — Investor Relations & Filings

Ticker · KRMD ISIN · US7599101026 US Manufacturing
Filings indexed 922 across all filing types
Latest filing 2025-08-06 Interim / Quarterly Rep…
Country US United States of America
Listing US KRMD

About KORU Medical Systems, Inc.

https://www.korumedical.com/

KORU Medical Systems is a medical technology company that designs, develops, manufactures, and commercializes subcutaneous infusion solutions. The company's primary offering is the Freedom™ Infusion System, which includes syringe infusion pumps and related accessories. These systems are engineered for the delivery of large-volume subcutaneous drugs, such as immunoglobulins, to treat patients with chronic illnesses. KORU Medical Systems focuses on providing patient-centric solutions that facilitate safe and effective home-based infusion therapy, aiming to enhance patient quality of life by offering greater freedom and flexibility in treatment management.

Recent filings

Filing Released Lang Actions
FORM 10-Q QUARTERLY REPORT FOR 06-30-2025
Interim / Quarterly Report Q2 2025
2025-08-06 English
FORM 8-K CURRENT REPORT FOR 08-06-2025
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 6, 2025, reporting the company's financial results for the second quarter ended June 30, 2025, and updated financial guidance for the fiscal year ending December 31, 2025. It includes a press release (Exhibit 99.1) announcing these results and mentions a related conference call. The document does not contain the full financial statements or detailed financial analysis itself but rather announces the results and references the press release and upcoming call. This fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights. The length (6364 characters) and content confirm it is not a full interim report (IR) or annual report (10-K). Therefore, the correct classification is Earnings Release (ER).
2025-08-06 English
FORM 4 FOR 07-02-2025
Director's Dealing
2025-07-02 English
FORM 4 FOR 07-02-2025
Director's Dealing
2025-07-02 English
FORM 4 FOR 07-02-2025
Director's Dealing
2025-07-02 English
FORM 4 FOR 07-02-2025
Director's Dealing
2025-07-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.